Liver is a very common site of ER+ breast cancer metastasis, with a clinical incidence rate of 40–50% (Cummings et al, 2014) and a high frequency of ESR1 alterations (Merenbakh-Lamin et al, 2013). This evidence concerns the gene ESR1 and breast cancer.